Before you sell to, join or invest in Branch Therapeutics, Inc.
MentionFox check on Branch Therapeutics, Inc.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/branch-therapeutics-inc-form-d-25000001
Check Branch Therapeutics, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Branch Therapeutics, Inc.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Branch Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2025-05-23.
Branch Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on May 23, 2025. The filing reports $4M sold. Its industry group is Pharmaceuticals. It names Curtis Thorne (CEO and Director), Christopher Hulme (Director), Sourav Banerjee (Director) (SEC Form D, May 23, 2025).
Is this your company?
Sell to companies like Branch Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-05-23 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Branch Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind Branch Therapeutics, Inc., from the filings we hold.
Pharmaceuticals raises filed within 90 days of this one, largest first.
Get an email when Branch Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Branch Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Branch Therapeutics, Inc. →Get the full cited report on Branch Therapeutics, Inc.
What the filing shows about Branch Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Branch Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Branch Therapeutics, Inc.'s address as 2450 Holcombe Blvd, Tmci Partners Office 1.319, Houston, TX 77021.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Branch Therapeutics, Inc. See pricing
Branch Therapeutics, Inc. is a registered filer with the SEC (CIK 2067625) and has filed since 2025-05-23. 1 filing is on record, the latest on 2025-05-23.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Branch Therapeutics, Inc.'s Form D of 2025-05-23 names Curtis Thorne, Christopher Hulme and Sourav Banerjee as its officers, directors or promoters.
Its new offerings report $4M sold across 1 offering, as its own filings state.
Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week.
On the filing as: Executive Officer, Director.
Curtis Thorne is named as Ceo and Director on the Form D that Branch Therapeutics, Inc. filed with the SEC on 23 May 2025, one of 3 people that filing names.
Christopher Hulme is named as Director on the Form D that Branch Therapeutics, Inc. filed with the SEC on 23 May 2025, one of 3 people that filing names.
Sourav Banerjee is named as Director on the Form D that Branch Therapeutics, Inc. filed with the SEC on 23 May 2025, one of 3 people that filing names.
3 people named on the filing — 1 holding an executive role and 2 as directors only.
Named as of the 2025-05-23 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Branch Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Branch Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Branch Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Branch Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Branch Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Branch Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Pharmaceuticals raises in Houston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/branch-therapeutics-inc-form-d-25000001